Lazertinib
CAS: 1903008-80-9
Ref. 3D-DBD00880
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
Lazertinib is a potent tyrosine kinase inhibitor with inhibitory properties against cancer cells. Lazertinib has been shown to have inhibitory effects on epidermal growth factor receptor (EGFR) and HER2/neu receptors, which are important for the growth of solid tumours. This drug inhibits the phosphorylation of these receptors, thereby blocking their downstream signalling pathways that promote cancer cell proliferation. Lazertinib also inhibits the activity of other tyrosine kinases including c-MET, AXL and RET, which may be important for inhibiting cancer cell growth in patients with autoimmune diseases.
Propiedades químicas
Consulta técnica sobre: 3D-DBD00880 Lazertinib
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
